Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.41 |
| ▸ | FDPS | P14324 | 9/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3608808 | 1.00 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL50029 | 1.00 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL51185 | 1.00 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL971499 | 1.00 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL3624293 | 1.00 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL10931906 | 1.00 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL23034285 | 1.00 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL8622066 | 1.00 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL21128 | 1.00 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL3624258 | 1.00 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3340283-B1 | WAFER WASHING METHOD, AND LIQUID CHEMICAL USED IN SAME | CENTRAL GLASS CO LTD (JP) | 2020-05-20 | — | — | EP | claimed |
| US-8945935-B2 | Diagnosing, prognosing and monitoring multiple sclerosis | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2015-02-03 | — | — | US | claimed |
| US-20130034910-A1 | DIAGNOSING, PROGNOSING AND MONITORING MULTIPLE SCLEROSIS | RAPPAPORT FAMILY INSTITUTE FOR RESEARCH IN THE MEDICAL SCIENCES (IL) | 2013-02-07 | — | — | US | claimed |
| US-12637563-B2 | Modifiers for polyesters that improve viscosity in melt | KANEKA AMERICAS HOLDING, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| US-20260015444-A1 | MODIFIERS FOR POLYESTERS THAT IMPROVE VISCOSITY IN MELT | KANEKA AMERICAS HOLDING, INC. (US) | 2026-01-15 | — | — | US | disclosed |
| US-11996557-B2 | Direct regeneration of lithium ion cathodes by ionothermal relithiation | UT-BATTELLE, LLC (US) | 2024-05-28 | — | — | US | disclosed |
| CN-116034116-B | Acrylic rubber excellent in roll processability, strength characteristics and water resistance | 日本瑞翁株式会社 | 2024-03-26 | — | — | CN | disclosed |
| WO-2024010749-A1 | MODIFIERS FOR POLYESTERS THAT IMPROVE VISCOSITY IN MELT | KANEKA AMERICAS HOLDING, INC. (US) | 2024-01-11 | — | — | WO | disclosed |
| US-11795583-B2 | Plasticized melt spinning process using ionic liquids for production of polyacrylonitrile fibers | UT-BATTELLE, LLC (US) | 2023-10-24 | — | — | US | disclosed |
| WO-2023182248-A1 | POWDERY BINDER FOR SECONDARY BATTERY POSITIVE ELECTRODE AND USE OF SAME | 東亞合成株式会社 | 2023-09-28 | — | — | WO | disclosed |
| US-11718758-B2 | Aqueous dispersion of colored particles | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2023-08-08 | — | — | US | disclosed |
| EP-1065242-A1 | EXPANDABLE VINYL CHLORIDE RESIN COMPOSITION | KANEKA CORPORATION (JP) | 2001-01-03 | — | — | EP | disclosed |
| US-5614550-A | ANTICHOLESTEROL AGENTS OR ARTERIOSCLEROSIS AGENTS FOR HUMANS | SANKYO COMPANY, LIMITED (JP) | 1997-03-25 | — | — | US | disclosed |
| US-5534529-A | Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO COMPANY, LIMITED (JP) | 1996-07-09 | — | — | US | disclosed |
| EP-0632036-A2 | Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO COMPANY LIMITED (JP) | 1995-01-04 | — | — | EP | disclosed |
| US-5324788-A | A copolymer of a 4-acyloxystyrene and an acrylate modified by an alcohol to effect an ester interchange, an aminoplast crosslinking agent and solvent; enamel coatings; acid and solvent resistance; hardness; gloss; autos | EASTMAN KODAK COMPANY (US) | 1994-06-28 | — | — | US | disclosed |
| US-4668740-A | BLENDS WITH METHYL METHACRYLATE COPOLYMERS | MITSUBISHI RAYON COMPANY, LTD. (JP) | 1987-05-26 | — | — | US | disclosed |
| US-4485170-A | BUTADIENE-STYRENE COPOLYMER, GELATIN | FUJI PHOTO FILM CO., LTD. (JP) | 1984-11-27 | — | — | US | disclosed |
| US-4437874-A | Tri-mixed alkylsulfonium salts of N-phosphonomethylgylcine and their use as plant growth regulators and herbicides | STAUFFER CHEMICAL COMPANY (US) | 1984-03-20 | — | — | US | disclosed |
| US-4423089-A | LATEX COPOLYMER CONSISTING OF DIOLEFIN, MONOVINYL MONOMER, AND POLYVINYL OR ACRYOYL MONOMER | FUJI PHOTO FILM CO., LTD. (JP) | 1983-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637563-B2 | Modifiers for polyesters that improve viscosity in melt | CRYAA, INCENP, CRYAB | TSHR 3985/4885THRB 3622/4885GGPS1 679/4885 |
| US-20260015444-A1 | MODIFIERS FOR POLYESTERS THAT IMPROVE VISCOSITY IN MELT | CRYAA, CRYAB, RCC1 | TSHR 3109/4885THRB 3503/4885GGPS1 323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.